Back to search

Article

Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma

2018-07-13

Abstract excerpt

<h4>ABSTRACT</h4> Dysregulation of the complement system is implicated in neurodegeneration, including human and animal glaucoma. Optic nerve and retinal damage in glaucoma is preceded by local complement upregulation and activation, but whether targeting this early innate immune response could have therapeutic benefit remains undefined. Because complement signals through three pathways that intersect at compleme...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2820260a-99c2-53e6-b9d0-0fed21344d2a
DOI
10.1101/369181
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucomaDOI 10.1101/369181
Select a neighboring publication to make it the new centre.